LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 41

Search options

  1. Article ; Online: Correction to: Genetically engineered probiotic Saccharomyces cerevisiae strains mature human dendritic cells and stimulate gag-specific memory CD8

    Palma, Mariana L / Garcia-Bates, Tatiana M / Martins, Flaviano S / Douradinha, Bruno

    Applied microbiology and biotechnology

    2019  Volume 103, Issue 13, Page(s) 5461

    Abstract: In the Funding section, the following statement is missing: The MACS cohort study was supported by the NIH, National Institute of Allergy and Infectious Diseases grant U01-AI35041. ...

    Abstract In the Funding section, the following statement is missing: The MACS cohort study was supported by the NIH, National Institute of Allergy and Infectious Diseases grant U01-AI35041.
    Language English
    Publishing date 2019-03-22
    Publishing country Germany
    Document type Journal Article ; Published Erratum
    ZDB-ID 392453-1
    ISSN 1432-0614 ; 0171-1741 ; 0175-7598
    ISSN (online) 1432-0614
    ISSN 0171-1741 ; 0175-7598
    DOI 10.1007/s00253-019-09911-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Genetically engineered probiotic Saccharomyces cerevisiae strains mature human dendritic cells and stimulate Gag-specific memory CD8

    Palma, Mariana L / Garcia-Bates, Tatiana M / Martins, Flaviano S / Douradinha, Bruno

    Applied microbiology and biotechnology

    2019  Volume 103, Issue 13, Page(s) 5183–5192

    Abstract: Recombinant Saccharomyces cerevisiae strains expressing HIV antigens have shown promising pre-clinical results. Probiotic S. cerevisiae strains naturally induce gut immunity; thus, genetically engineered probiotic strains could be used to stimulate ... ...

    Abstract Recombinant Saccharomyces cerevisiae strains expressing HIV antigens have shown promising pre-clinical results. Probiotic S. cerevisiae strains naturally induce gut immunity; thus, genetically engineered probiotic strains could be used to stimulate immune responses against HIV in the mucosa. Probiotic strains have a higher rate of heterologous protein production, meaning higher antigen's epitope expression levels per yeast cell. We expressed HIV-1 Gag protein in the probiotic yeasts' surface, which was eagerly phagocytosed by and induced type 1 polarization of human monocyte-derived dendritic cells (DCs) from healthy donors in vitro. We further matured DCs derived from HIV-1
    MeSH term(s) AIDS Vaccines/immunology ; Antigen Presentation ; CD8-Positive T-Lymphocytes/immunology ; Cell Differentiation ; Dendritic Cells/immunology ; Genetic Engineering ; HIV-1/genetics ; HIV-1/immunology ; Humans ; Immunologic Memory ; Male ; Phagocytosis ; Probiotics ; Saccharomyces cerevisiae/genetics ; Saccharomyces cerevisiae/immunology ; Th1 Cells/immunology ; gag Gene Products, Human Immunodeficiency Virus/genetics ; gag Gene Products, Human Immunodeficiency Virus/immunology
    Chemical Substances AIDS Vaccines ; gag Gene Products, Human Immunodeficiency Virus
    Language English
    Publishing date 2019-04-24
    Publishing country Germany
    Document type Journal Article
    ZDB-ID 392453-1
    ISSN 1432-0614 ; 0171-1741 ; 0175-7598
    ISSN (online) 1432-0614
    ISSN 0171-1741 ; 0175-7598
    DOI 10.1007/s00253-019-09842-8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Correction to: Genetically engineered probiotic Saccharomyces cerevisiae strains mature human dendritic cells and stimulate gag-specific memory CD8+ T cells ex vivo

    Palma, Mariana L / Douradinha, Bruno / Garcia-Bates, Tatiana M / Martins, Flaviano S

    Applied microbiology and biotechnology. 2019 July, v. 103, no. 13

    2019  

    Abstract: In the Funding section, the following statement is missing: The MACS cohort study was supported by the NIH, National Institute of Allergy and Infectious Diseases grant U01-AI35041. ...

    Abstract In the Funding section, the following statement is missing: The MACS cohort study was supported by the NIH, National Institute of Allergy and Infectious Diseases grant U01-AI35041.
    Keywords CD8-positive T-lymphocytes ; cohort studies ; dendritic cells ; genetic engineering ; humans ; probiotics ; Saccharomyces cerevisiae
    Language English
    Dates of publication 2019-07
    Size p. 5461.
    Publishing place Springer Berlin Heidelberg
    Document type Article
    Note Published Erratum
    ZDB-ID 392453-1
    ISSN 1432-0614 ; 0171-1741 ; 0175-7598
    ISSN (online) 1432-0614
    ISSN 0171-1741 ; 0175-7598
    DOI 10.1007/s00253-019-09911-y
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  4. Article ; Online: Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.

    Kristoff, Jan / Palma, Mariana L / Garcia-Bates, Tatiana M / Shen, Chengli / Sluis-Cremer, Nicolas / Gupta, Phalguni / Rinaldo, Charles R / Mailliard, Robbie B

    EBioMedicine

    2019  Volume 43, Page(s) 295–306

    Abstract: Background: Despite the success of antiretroviral therapy (ART), latent HIV-1 continues to persist in a long-lived population of resting memory CD4: Methods: In this study, we test the use of antigen-presenting type 1-polarized, monocyte-derived ... ...

    Abstract Background: Despite the success of antiretroviral therapy (ART), latent HIV-1 continues to persist in a long-lived population of resting memory CD4
    Methods: In this study, we test the use of antigen-presenting type 1-polarized, monocyte-derived dendritic cells (MDC1) generated from chronic HIV-1-infected individuals on ART as a means to induce HIV-1 latency reversal in autologous CD4
    Findings: MDC1 presentation of either HIV-1 or cytomegalovirus (CMV) antigens to CD4
    Interpretation: Inclusion of virus-associated MHC class II 'helper' antigens in MDC1-based HIV-1 immunotherapies could serve both as a targeted means to safely unmask antigen-specific CD4
    MeSH term(s) Antigens, Viral ; Biomarkers ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/metabolism ; CD4-Positive T-Lymphocytes/virology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Dendritic Cells/immunology ; Dendritic Cells/metabolism ; Epitopes/immunology ; HIV Infections/drug therapy ; HIV Infections/immunology ; HIV Infections/metabolism ; HIV Infections/virology ; HIV-1/physiology ; Host-Pathogen Interactions/immunology ; Humans ; Interferon-gamma/metabolism ; RNA, Viral ; T-Lymphocytes, Cytotoxic/immunology ; Virus Latency/immunology ; Virus Replication
    Chemical Substances Antigens, Viral ; Biomarkers ; Epitopes ; RNA, Viral ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2019-04-02
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2851331-9
    ISSN 2352-3964
    ISSN (online) 2352-3964
    DOI 10.1016/j.ebiom.2019.03.077
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Genetically engineered probiotic Saccharomyces cerevisiae strains mature human dendritic cells and stimulate Gag-specific memory CD8+ T cells ex vivo

    Palma, Mariana L / Douradinha, Bruno / Garcia-Bates, Tatiana M / Martins, Flaviano S

    Applied microbiology and biotechnology. 2019 July, v. 103, no. 13

    2019  

    Abstract: Recombinant Saccharomyces cerevisiae strains expressing HIV antigens have shown promising pre-clinical results. Probiotic S. cerevisiae strains naturally induce gut immunity; thus, genetically engineered probiotic strains could be used to stimulate ... ...

    Abstract Recombinant Saccharomyces cerevisiae strains expressing HIV antigens have shown promising pre-clinical results. Probiotic S. cerevisiae strains naturally induce gut immunity; thus, genetically engineered probiotic strains could be used to stimulate immune responses against HIV in the mucosa. Probiotic strains have a higher rate of heterologous protein production, meaning higher antigen’s epitope expression levels per yeast cell. We expressed HIV-1 Gag protein in the probiotic yeasts’ surface, which was eagerly phagocytosed by and induced type 1 polarization of human monocyte-derived dendritic cells (DCs) from healthy donors in vitro. We further matured DCs derived from HIV-1+ donors with transformed yeasts and incubated them with autologous T cells. Only DCs matured with Gag-expressing probiotic strains were able to efficiently present antigen to CD8+ T cells and induced their clonal expansion. Our results show that genetically engineered probiotic S. cerevisiae strains are a promising vaccination strategy against HIV.
    Keywords CD8-positive T-lymphocytes ; dendritic cells ; digestive system ; epitopes ; genetic engineering ; heterologous gene expression ; Human immunodeficiency virus 1 ; humans ; immune response ; mucosa ; probiotics ; Saccharomyces cerevisiae ; vaccination ; yeasts
    Language English
    Dates of publication 2019-07
    Size p. 5183-5192.
    Publishing place Springer Berlin Heidelberg
    Document type Article
    ZDB-ID 392453-1
    ISSN 1432-0614 ; 0171-1741 ; 0175-7598
    ISSN (online) 1432-0614
    ISSN 0171-1741 ; 0175-7598
    DOI 10.1007/s00253-019-09842-8
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  6. Article ; Online: Contrasting Roles of the PD-1 Signaling Pathway in Dendritic Cell-Mediated Induction and Regulation of HIV-1-Specific Effector T Cell Functions.

    Garcia-Bates, Tatiana M / Palma, Mariana L / Shen, Chengli / Gambotto, Andrea / Macatangay, Bernard J C / Ferris, Robert L / Rinaldo, Charles R / Mailliard, Robbie B

    Journal of virology

    2019  Volume 93, Issue 5

    Abstract: Eliciting highly functional ... ...

    Abstract Eliciting highly functional CD8
    MeSH term(s) Adult ; B7-H1 Antigen/metabolism ; CD40 Ligand/metabolism ; Dendritic Cells/immunology ; HIV Infections/immunology ; HIV-1/immunology ; Humans ; Immune Evasion/immunology ; Immunologic Memory/immunology ; Interleukin-12 Subunit p35/immunology ; Lymphocyte Activation/immunology ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; Programmed Cell Death 1 Receptor/metabolism ; Signal Transduction/immunology ; T-Lymphocytes, Cytotoxic/immunology ; T-Lymphocytes, Helper-Inducer/immunology
    Chemical Substances B7-H1 Antigen ; CD274 protein, human ; IL12A protein, human ; Interleukin-12 Subunit p35 ; PDCD1 protein, human ; Programmed Cell Death 1 Receptor ; CD40 Ligand (147205-72-9)
    Language English
    Publishing date 2019-02-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 80174-4
    ISSN 1098-5514 ; 0022-538X
    ISSN (online) 1098-5514
    ISSN 0022-538X
    DOI 10.1128/JVI.02035-18
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.

    Garcia-Bates, Tatiana M / Palma, Mariana L / Anderko, Renee R / Hsu, Denise C / Ananworanich, Jintanat / Korber, Bette T / Gaiha, Gaurav D / Phanuphak, Nittaya / Thomas, Rasmi / Tovanabutra, Sodsai / Walker, Bruce D / Mellors, John W / Piazza, Paolo A / Kroon, Eugene / Riddler, Sharon A / Michael, Nelson L / Rinaldo, Charles R / Mailliard, Robbie B

    EBioMedicine

    2021  Volume 63, Page(s) 103175

    Abstract: Background: During early HIV-1 infection, immunodominant T cell responses to highly variable epitopes lead to the establishment of immune escape virus variants. Here we assessed a type 1-polarized monocyte-derived dendritic cell (MDC1)-based approach to ...

    Abstract Background: During early HIV-1 infection, immunodominant T cell responses to highly variable epitopes lead to the establishment of immune escape virus variants. Here we assessed a type 1-polarized monocyte-derived dendritic cell (MDC1)-based approach to selectively elicit cytotoxic T lymphocyte (CTL) responses against highly conserved and topologically important HIV-1 epitopes in HIV-1-infected individuals from the Thailand RV254/SEARCH 010 cohort who initiated antiretroviral therapy (ART) during early infection (Fiebig stages I-IV).
    Methods: Autologous MDC1 were used as antigen presenting cells to induce in vitro CTL responses against HIV-1 Gag, Pol, Env, and Nef as determined by flow cytometry and ELISpot assay. Ultra-conserved or topologically important antigens were respectively identified using the Epigraph tool and a structure-based network analysis approach and compared to overlapping peptides spanning the Gag proteome.
    Findings: MDC1 presenting either the overlapping Gag, Epigraph, or Network 14-21mer peptide pools consistently activated and expanded HIV-1-specific T cells to epitopes identified at the 9-13mer peptide level. Interestingly, some CTL responses occurred outside known or expected HLA associations, providing evidence of new HLA-associated CTL epitopes. Comparative analyses demonstrated more sequence conservation among Epigraph antigens but a higher magnitude of CTL responses to Network and Gag peptide groups. Importantly, CTL responses against topologically constrained Gag epitopes contained in both the Network and Gag peptide pools were selectively enhanced in the Network pool-initiated cultures.
    Interpretation: Our study supports the use of MDC1 as a therapeutic strategy to induce and focus CTL responses toward putative fitness-constrained regions of HIV-1 to prevent immune escape and control HIV-1 infection.
    Funding: A full list of the funding sources is detailed in the Acknowledgment section of the manuscript.
    MeSH term(s) Adult ; Alleles ; Amino Acid Sequence ; CD4 Lymphocyte Count ; CD4-CD8 Ratio ; Conserved Sequence ; Dendritic Cells/immunology ; Dendritic Cells/metabolism ; Epitopes, T-Lymphocyte/chemistry ; Epitopes, T-Lymphocyte/immunology ; Genotype ; HIV Infections/genetics ; HIV Infections/immunology ; HIV Infections/virology ; HIV-1/genetics ; HIV-1/immunology ; HLA Antigens/genetics ; HLA Antigens/immunology ; Host-Pathogen Interactions/genetics ; Host-Pathogen Interactions/immunology ; Humans ; Immunophenotyping ; Middle Aged ; Peptides/chemistry ; Peptides/immunology ; T-Lymphocytes, Cytotoxic/immunology ; T-Lymphocytes, Cytotoxic/metabolism
    Chemical Substances Epitopes, T-Lymphocyte ; HLA Antigens ; Peptides
    Language English
    Publishing date 2021-01-12
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2851331-9
    ISSN 2352-3964
    ISSN (online) 2352-3964
    DOI 10.1016/j.ebiom.2020.103175
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients.

    Mazorra, Zaima / Lavastida, Anabel / Concha-Benavente, Fernando / Valdés, Anet / Srivastava, Raghvendra M / García-Bates, Tatiana M / Hechavarría, Esperanza / González, Zuyen / González, Amnely / Lugiollo, Martha / Cuevas, Iván / Frómeta, Carlos / Mestre, Braulio F / Barroso, Maria C / Crombet, Tania / Ferris, Robert L

    Frontiers in pharmacology

    2017  Volume 8, Page(s) 382

    Abstract: Survival benefit and long-term duration of clinical response have been seen using the epidermal growth factor receptor (EGFR)-targeted monoclonal antibody (mAb) nimotuzumab. Blocking EGFR signaling may not be the only mechanism of action underlying its ... ...

    Abstract Survival benefit and long-term duration of clinical response have been seen using the epidermal growth factor receptor (EGFR)-targeted monoclonal antibody (mAb) nimotuzumab. Blocking EGFR signaling may not be the only mechanism of action underlying its efficacy. As an IgG1 isotype mAb, nimotuzumab's capacity of killing tumor cells by antibody dependent cellular cytotoxicity (ADCC) and to induce an immune response in cancer patients have not been studied. ADCC-induced by nimotuzumab was determined using a
    Language English
    Publishing date 2017-06-19
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2587355-6
    ISSN 1663-9812
    ISSN 1663-9812
    DOI 10.3389/fphar.2017.00382
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article: Anti-EGFR Targeted Monoclonal Antibody Isotype Influences Antitumor Cellular Immunity in Head and Neck Cancer Patients.

    Trivedi, Sumita / Srivastava, Raghvendra M / Concha-Benavente, Fernando / Ferrone, Soldano / Garcia-Bates, Tatiana M / Li, Jing / Ferris, Robert L

    Clinical cancer research : an official journal of the American Association for Cancer Research

    2016  Volume 22, Issue 21, Page(s) 5229–5237

    Abstract: Purpose: EGF receptor (EGFR) is highly overexpressed on several cancers and two targeted anti-EGFR antibodies which differ by isotype are FDA-approved for clinical use. Cetuximab (IgG1 isotype) inhibits downstream signaling of EGFR and activates ... ...

    Abstract Purpose: EGF receptor (EGFR) is highly overexpressed on several cancers and two targeted anti-EGFR antibodies which differ by isotype are FDA-approved for clinical use. Cetuximab (IgG1 isotype) inhibits downstream signaling of EGFR and activates antitumor, cellular immune mechanisms. As panitumumab (IgG2 isotype) may inhibit downstream EGFR signaling similar to cetuximab, it might also induce adaptive immunity.
    Experimental design: We measured in vitro activation of cellular components of the innate and adaptive immune systems. We also studied the in vivo activation of components of the adaptive immune system in patient specimens from two recent clinical trials using cetuximab or panitumumab.
    Results: Both monoclonal antibodies (mAb) primarily activate natural killer (NK) cells, although cetuximab is significantly more potent than panitumumab. Cetuximab-activated neutrophils mediate antibody-dependent cellular cytotoxicity (ADCC) against head and neck squamous cell carcinomas (HNSCC) tumor cells, and interestingly, this effect was FcγRIIa- and FcγRIIIa genotype-dependent. Panitumumab may activate monocytes through CD32 (FcγRIIa); however, monocytes activated by either mAb are not able to mediate ADCC. Cetuximab enhanced dendritic cell (DC) maturation to a greater extent than panitumumab, which was associated with improved tumor antigen cross-presentation by cetuximab compared with panitumumab. This correlated with increased EGFR-specific cytotoxic CD8
    Conclusions: Although panitumumab effectively inhibits EGFR signaling to a similar extent as cetuximab, it is less effective at triggering antitumor, cellular immune mechanisms which may be crucial for effective therapy of HNSCC. Clin Cancer Res; 22(21); 5229-37. ©2016 AACR.
    MeSH term(s) Antibodies, Monoclonal/immunology ; Antibodies, Monoclonal/therapeutic use ; CD8-Positive T-Lymphocytes/drug effects ; CD8-Positive T-Lymphocytes/immunology ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/immunology ; Cetuximab/immunology ; Cetuximab/therapeutic use ; Dendritic Cells/drug effects ; Dendritic Cells/immunology ; ErbB Receptors/antagonists & inhibitors ; ErbB Receptors/immunology ; Head and Neck Neoplasms/drug therapy ; Head and Neck Neoplasms/immunology ; Humans ; Immunity, Cellular/drug effects ; Immunity, Cellular/immunology ; Immunoglobulin G/immunology ; Killer Cells, Natural/drug effects ; Killer Cells, Natural/immunology ; Monocytes/drug effects ; Monocytes/immunology ; Panitumumab ; Receptors, IgG/immunology ; Squamous Cell Carcinoma of Head and Neck ; T-Lymphocytes, Cytotoxic/drug effects ; T-Lymphocytes, Cytotoxic/immunology
    Chemical Substances Antibodies, Monoclonal ; Fc gamma receptor IIA ; Fc gamma receptor IIC ; Immunoglobulin G ; Receptors, IgG ; Panitumumab (6A901E312A) ; EGFR protein, human (EC 2.7.10.1) ; ErbB Receptors (EC 2.7.10.1) ; Cetuximab (PQX0D8J21J)
    Language English
    Publishing date 2016-05-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1225457-5
    ISSN 1557-3265 ; 1078-0432
    ISSN (online) 1557-3265
    ISSN 1078-0432
    DOI 10.1158/1078-0432.CCR-15-2971
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Enhanced Cytotoxic CD8 T Cell Priming Using Dendritic Cell-Expressing Human Papillomavirus-16 E6/E7-p16INK4 Fusion Protein with Sequenced Anti-Programmed Death-1.

    Garcia-Bates, Tatiana M / Kim, Eun / Concha-Benavente, Fernando / Trivedi, Sumita / Mailliard, Robbie B / Gambotto, Andrea / Ferris, Robert L

    Journal of immunology (Baltimore, Md. : 1950)

    2016  Volume 196, Issue 6, Page(s) 2870–2878

    Abstract: The incidence of human papillomavirus (HPV)-related head and neck squamous cell carcinoma has increased in recent decades, though HPV prevention vaccines may reduce this rise in the future. HPV-related cancers express the viral oncoproteins E6 and E7. ... ...

    Abstract The incidence of human papillomavirus (HPV)-related head and neck squamous cell carcinoma has increased in recent decades, though HPV prevention vaccines may reduce this rise in the future. HPV-related cancers express the viral oncoproteins E6 and E7. The latter inactivates the tumor suppressor protein retinoblastoma (Rb), which leads to the overexpression of p16(INK4) protein, providing unique Ags for therapeutic HPV-specific cancer vaccination. We developed potential adenoviral vaccines that express a fusion protein of HPV-16 E6 and E7 (Ad.E6E7) alone or fused with p16 (Ad.E6E7p16) and also encoding an anti-programmed death (PD)-1 Ab. Human monocyte-derived dendritic cells (DC) transduced with Ad.E6E7 or Ad.E6E7p16 with or without Ad.αPD1 were used to activate autologous CD8 CTL in vitro. CTL responses were tested against naturally HPV-infected head and neck squamous cell carcinoma cells using IFN-γ ELISPOT and [(51)Cr]release assay. Surprisingly, stimulation and antitumor activity of CTL were increased after incubation with Ad.E6E7p16-transduced DC (DC.E6E7p16) compared with Ad.E6E7 (DC.E6E7), a result that may be due to an effect of p16 on cyclin-dependent kinase 4 levels and IL-12 secretion by DC. Moreover, the beneficial effect was most prominent when anti-PD-1 was introduced during the second round of stimulation (after initial priming). These data suggest that careful sequencing of Ad.E6E7.p16 with Ad.αPD1 could improve antitumor immunity against HPV-related tumors and that p16 may enhance the immunogenicity of DC, through cyclin-dependent pathways, Th1 cytokine secretion, and by adding a nonviral Ag highly overexpressed in HPV-induced cancers.
    MeSH term(s) Adenoviridae/genetics ; Antibodies/genetics ; Antibodies/metabolism ; CD8-Positive T-Lymphocytes/immunology ; Cancer Vaccines/administration & dosage ; Cyclin-Dependent Kinase 4/metabolism ; Cyclin-Dependent Kinase Inhibitor p16/genetics ; Cyclin-Dependent Kinase Inhibitor p16/metabolism ; Cytotoxicity, Immunologic ; Dendritic Cells/immunology ; Dendritic Cells/transplantation ; Head and Neck Neoplasms/immunology ; Head and Neck Neoplasms/therapy ; Human papillomavirus 16/immunology ; Humans ; Interferon-gamma/metabolism ; Interleukin-12/metabolism ; Mutation/genetics ; Neoplasms, Squamous Cell/immunology ; Neoplasms, Squamous Cell/therapy ; Oncogene Proteins, Viral/genetics ; Oncogene Proteins, Viral/metabolism ; Papillomavirus Infections/immunology ; Papillomavirus Infections/therapy ; Programmed Cell Death 1 Receptor/immunology ; Recombinant Fusion Proteins/genetics ; Recombinant Fusion Proteins/metabolism ; Repressor Proteins/genetics ; Repressor Proteins/metabolism
    Chemical Substances Antibodies ; Cancer Vaccines ; Cyclin-Dependent Kinase Inhibitor p16 ; E6 protein, Human papillomavirus type 16 ; E7 protein, Human papillomavirus type 33 ; Oncogene Proteins, Viral ; PDCD1 protein, human ; Programmed Cell Death 1 Receptor ; Recombinant Fusion Proteins ; Repressor Proteins ; Interleukin-12 (187348-17-0) ; Interferon-gamma (82115-62-6) ; Cyclin-Dependent Kinase 4 (EC 2.7.11.22)
    Language English
    Publishing date 2016-03-15
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 3056-9
    ISSN 1550-6606 ; 0022-1767 ; 1048-3233 ; 1047-7381
    ISSN (online) 1550-6606
    ISSN 0022-1767 ; 1048-3233 ; 1047-7381
    DOI 10.4049/jimmunol.1502027
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top